as 07-26-2024 4:00pm EST
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.
Founded: | 1992 | Country: | United States |
Employees: | N/A | City: | N/A |
Market Cap: | 384.8M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 120.9K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 0.79 | EPS Growth: | N/A |
52 Week Low/High: | $11.34 - $14.37 | Next Earning Date: | 01-01-0001 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
DiMartino Rose | HQL | Director | Jul 16 '24 | Buy | $15.53 | 1,000 | $15,530.00 | 1,000 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Jun 26 '24 | Buy | $14.07 | 100 | $1,407.00 | 3,429,991 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Jun 24 '24 | Buy | $14.08 | 13,812 | $194,472.96 | 3,429,891 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Jun 12 '24 | Buy | $13.88 | 2,400 | $33,312.00 | 3,407,612 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Jun 12 '24 | Buy | $13.82 | 8,467 | $117,013.94 | 3,416,079 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Jun 10 '24 | Buy | $13.71 | 9,704 | $133,041.84 | 3,403,173 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Jun 10 '24 | Buy | $13.76 | 2,039 | $28,056.64 | 3,405,212 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Jun 6 '24 | Buy | $13.80 | 9,598 | $132,452.40 | 3,389,706 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Jun 6 '24 | Buy | $13.72 | 3,763 | $51,628.36 | 3,393,469 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Jun 4 '24 | Buy | $13.50 | 33,357 | $450,319.50 | 3,354,025 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Jun 4 '24 | Buy | $13.76 | 26,083 | $358,902.08 | 3,380,108 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 28 '24 | Buy | $13.38 | 8,714 | $116,593.32 | 3,260,597 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 28 '24 | Buy | $13.09 | 38,033 | $497,851.97 | 3,298,630 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 28 '24 | Buy | $13.05 | 669 | $8,730.45 | 3,299,299 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 23 '24 | Buy | $13.50 | 1,303 | $17,590.50 | 3,251,883 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 15 '24 | Buy | $14.19 | 34,755 | $493,173.45 | 3,250,580 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 10 '24 | Buy | $13.86 | 57,862 | $801,967.32 | 3,215,825 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 8 '24 | Buy | $13.70 | 10,986 | $150,508.20 | 3,140,590 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 8 '24 | Buy | $13.80 | 17,373 | $239,747.40 | 3,157,963 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 6 '24 | Buy | $13.62 | 10,713 | $145,911.06 | 3,079,443 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 6 '24 | Buy | $13.76 | 50,161 | $690,215.36 | 3,129,604 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 1 '24 | Buy | $13.02 | 252 | $3,281.04 | 3,042,456 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | May 1 '24 | Buy | $13.46 | 26,274 | $353,648.04 | 3,068,730 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Apr 30 '24 | Buy | $13.13 | 16,573 | $217,603.49 | 3,042,204 | SEC Form 4 |
Saba Capital Management, L.P. | HQL | 10% Owner | Apr 26 '24 | Buy | $13.00 | 120,304 | $1,563,952.00 | 3,025,602 | SEC Form 4 |
HQL Breaking Stock News: Dive into HQL Ticker-Specific Updates for Smart Investing
ACCESSWIRE
a month ago
ACCESSWIRE
a month ago
Business Wire
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
Simply Wall St.
2 months ago
Reuters
2 months ago
AFP
2 months ago
The information presented on this page, "HQL abrdn Life Sciences Investors Shares of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.